A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer
Conditions
Interventions
- DRUG: Gemcitabine Oxaliplatin 5FU and Leucovorin
Sponsor
National Health Research Institutes, Taiwan
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]